Antipsychotic drugs; vendor drug program; Oklahoma Health Care Authority; prior authorized; disorders; prior authorization; effective date.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 4 Compare versions History 15 Sponsors

Apr 1, 2025 · Senate

Second Reading referred to Health and Human Services Committee then to Appropriations Committee

Mar 11, 2025 · House

Engrossed, signed, to Senate

Mar 11, 2025 · Senate

First Reading

Mar 10, 2025 · House

General Order

Mar 10, 2025 · House

Amended

Mar 10, 2025 · House

Title stricken

Mar 10, 2025 · House

Third Reading, Measure passed: Ayes: 87 Nays: 0

Mar 10, 2025 · House

Referred for engrossment

Feb 26, 2025 · House

CR; Do Pass Health and Human Services Oversight Committee

Feb 24, 2025 · House

Policy recommendation to the Health and Human Services Oversight committee; Do Pass Public Health

Feb 24, 2025 · House

Authored by Senator Stanley (principal Senate author)

Feb 4, 2025 · House

Second Reading referred to Health and Human Services Oversight

Feb 4, 2025 · House

Referred to Public Health

Feb 3, 2025 · House

First Reading

Feb 3, 2025 · House

Authored by Representative Marti

PASSAGE PROBABILITY

24.6% Unlikely

Why this number

Stage base Passed First Chamber — base rate 45%, measured from OK's completed sessions
Momentum +2 59/100 from the pace of recorded action
Time since last action -22 560 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.